PCVX (PCVX): insider Andrew Guggenhime plans 10,000-share stock sale

Rhea-AI Filing Summary

PCVX insider Andrew Guggenhime filed to sell 10,000 shares of common stock through UBS Financial Services on NASDAQ on 08/03/2026, in connection with an exercise of stock options for cash. The planned sale has an indicated aggregate value of $539,900.00.

Over the prior three months, Guggenhime reported selling 10,000 shares of common stock on 06/18/2026 for $530,000.00 and another 10,000 shares on 07/06/2026 for $572,836.00.

Key Figures

Planned shares to be sold: 10,000 shares Planned sale value: $539,900.00 Past sale 1 shares: 10,000 shares +3 more

6 metrics

Planned shares to be sold 10,000 shares Common stock sale expected on 08/03/2026 via UBS Financial Services on NASDAQ

Planned sale value $539,900.00 Aggregate value indicated for the 10,000 shares to be sold on 08/03/2026

Past sale 1 shares 10,000 shares Common stock sold on 06/18/2026

Past sale 1 value $530,000.00 Aggregate value for 10,000 shares sold on 06/18/2026

Past sale 2 shares 10,000 shares Common stock sold on 07/06/2026

Past sale 2 value $572,836.00 Aggregate value for 10,000 shares sold on 07/06/2026

Key Terms

Form 144, Exercise of Stock Options, Securities To Be Sold

3 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 08/03/2026 | Exercise of Stock Options | Issuer"

Securities To Be Sold regulatory

"144: Securities To Be Sold"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/03/2026 - 04:17 PM Accepted by SEC EDGAR 08/03/2026 - 04:16 PM Learn about SEC filing dates

FAQ

What stock sale is disclosed for PCVX in this Form 144 filing?

The filing reports a planned sale of 10,000 shares of PCVX common stock on 08/03/2026 via UBS Financial Services, with an indicated aggregate value of $539,900.00.

Who is the reporting person in the PCVX Form 144 and what is being sold?

The reporting person is Andrew Guggenhime, who plans to sell 10,000 shares of PCVX common stock on 08/03/2026 in connection with an exercise of stock options.

What were the recent PCVX stock sales reported over the past three months?

Recent activity includes two sales by Andrew Guggenhime: 10,000 shares on 06/18/2026 for $530,000.00 and 10,000 shares on 07/06/2026 for $572,836.00.

Through which broker will the PCVX Form 144 shares be sold?

The planned 10,000-share sale of PCVX common stock is to be executed through UBS Financial Services, Inc., located at 11 Madison Ave, 4th Floor, New York, NY 10010.

On which market will the PCVX Form 144 shares be sold and on what date?

The filing indicates that 10,000 shares of PCVX common stock are expected to be sold on the NASDAQ market on 08/03/2026, tied to an exercise of stock options.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc 11 Madison Ave 4th Floor New York NY 10010	10000	539900.00	144397682	08/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/03/2026	Exercise of Stock Options	Issuer			10000	08/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Guggenhime 825 Industrial Road, Suite 300 San Carlos CA 94070	Common	06/18/2026	10000	530000.00
Andrew Guggenhime 825 Industrial Road, Suite 300 San Carlos CA 94070	Common	07/06/2026	10000	572836.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)